ESR1 and breast carcinoma: Interestingly, in the case of triple-negative breast cancer cell lines, we found that the potential of PLT to inhibit cell survival/proliferation was also promising, or even comparable to that obtained for the studied estrogen receptor-positive breast cancer cell lines (data not shown).